Home > Newsletters > FDAnews Device Daily Bulletin > Covidien Warning Letter Follows January Surgical Staple Recall
FDAnews Device Daily Bulletin
July 10, 2012 | Vol. 9 No. 134
Covidien Warning Letter Follows January Surgical Staple Recall
Covidien’s January recall of a surgical staple product hasn’t ended the company’s troubles, as an FDA warning letter questioning Covidien’s handling of safety concerns makes clear. The June 14 letter from the FDA’s New England District Office follows a Jan. 13-Feb. 9 inspection of Covidien’s New Haven, Conn., manufacturing plant.
The GMP Letter
ePublishing :: CMS, Hosting & Web Development | © Copyright by FDAnewsAll rights reserved. Do not duplicate or redistribute in any form.